Clinical Safety and Efficacy of Flow-diverter in the Treatment of Intracranial Aneurysms

NCT06943729 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 523

Last updated 2025-08-29

No results posted yet for this study

Summary

To collect the safety and effectiveness data of flow-di in the treatment of intracranial aneurysms in real-world clinical practice, verify its classification of treatment strategies for aneurysms of different locations and shapes, and optimize postoperative medication regimen, provide long-term evidence-based basis for clinical treatment of intracranial aneurysms, and build a database.

Conditions

  • Flow Diverter

Sponsors & Collaborators

  • Xinqiao Hospital of Chongqing

    collaborator OTHER
  • Ningbo No.2 Hospital

    collaborator OTHER
  • Eighth Affiliated Hospital, Sun Yat-sen University

    collaborator OTHER
  • Second Affiliated Hospital of Nanchang University

    collaborator OTHER
  • Jiangxi Provincial People's Hopital

    collaborator OTHER
  • Zhengzhou Central Hospital

    collaborator OTHER
  • Xuchang Central Hospital

    collaborator UNKNOWN
  • Second People's Hospital of Hunan

    collaborator OTHER
  • People's Hospital Of Ningxiang City

    collaborator UNKNOWN
  • The First People's Hospital of Changde City

    collaborator OTHER
  • HUANG GANG Central Hospital

    collaborator UNKNOWN
  • Xianning Central Hospital

    collaborator OTHER
  • Jingzhou Central Hospital

    collaborator OTHER
  • Yichang Central People's Hospital

    collaborator OTHER
  • The First People's Hospital of Changzhou

    collaborator OTHER
  • The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

    collaborator OTHER
  • Northern Jiangsu People's Hospital

    collaborator OTHER
  • Suzhou Municipal Hospital

    collaborator OTHER
  • Jiangsu Taizhou People's Hospital

    collaborator OTHER
  • Huadong Hospital

    collaborator OTHER
  • RenJi Hospital

    collaborator OTHER
  • Shanghai Zhongshan Hospital

    collaborator OTHER
  • Shanghai Fourth People's Hospital

    collaborator UNKNOWN
  • Shanghai Donglei Brain Hospital

    collaborator UNKNOWN
  • Shanghai Pudong New Area People's Hospital

    collaborator OTHER
  • Shanghai East Hospital of Tongji University

    collaborator OTHER
  • First Affiliated Hospital Xi'an Jiaotong University

    collaborator OTHER
  • Second Affiliated Hospital of Xi'an Jiaotong University

    collaborator OTHER
  • Tangshan Gongren Hospital

    collaborator OTHER
  • The Second Hospital of Hebei Medical University

    collaborator OTHER
  • Hebei General Hospital

    collaborator OTHER
  • Xingtai People's Hospital

    collaborator OTHER
  • Peking University First Hospital

    collaborator OTHER
  • THE AFFILIATED SUZHOU HOSPITAL OF NANJING UNIVERSITY MEDICAL SCHOOL

    collaborator UNKNOWN
  • The Second Affiliated Hospital of Kunming Medical University

    collaborator OTHER
  • Huashan Hospital

    lead OTHER

Principal Investigators

  • Gu Yuxiang, PhD · department of Neurosurgery, Huashan Hospital,Fudan University

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-04-27
Primary Completion
2026-12-30
Completion
2027-04-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06943729 on ClinicalTrials.gov